NIKU SINGH
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- MCLEAN, VA
- NPI
- 1558374595
- Received
- $2,463,730 in 3,556 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 701 | $608,084 |
| 2024 | General payment | 610 | $468,842 |
| 2023 | General payment | 589 | $463,321 |
| 2022 | General payment | 609 | $426,738 |
| 2021 | General payment | 453 | $222,949 |
| 2020 | General payment | 262 | $122,062 |
| 2019 | General payment | 332 | $151,731 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 794 | $1,653,109 |
| Travel and Lodging | 1,051 | $451,397 |
| Consulting Fee | 72 | $182,012 |
| Honoraria | 38 | $109,275 |
| Food and Beverage | 1,591 | $67,692 |
| Education | 10 | $244 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-16 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,960 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $219 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-09 | Lundbeck LLC | $34 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-08 | Collegium Pharmaceutical, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-12-04 | Axsome Therapeutics, Inc. | $129 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-04 | Alkermes, Inc. | $67 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-02 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-02 | Axsome Therapeutics, Inc. | $56 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-02 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $14 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-26 | E.R. Squibb & Sons, L.L.C. | $1,840 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-26 | ABBVIE INC. | $1,100 | Consulting Fee | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,080 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-20 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | Vanda Pharmaceuticals Inc. | $113 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $93 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $72 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $53 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-14 | Otsuka America Pharmaceutical, Inc. | $55 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-14 | Alkermes, Inc. | $31 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-14 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $41 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-07 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | Otsuka America Pharmaceutical, Inc. | $122 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $598 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $527 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $219 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $95 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-24 | Otsuka America Pharmaceutical, Inc. | $2,106 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,104 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $95 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $907 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $554 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $120 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-21 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-21 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-10-17 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-17 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $3,850 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $583 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $311 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $66 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $58 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $44 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $36 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-16 | Axsome Therapeutics, Inc. | $23 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $926 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $306 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $188 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $144 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $65 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $56 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | Otsuka America Pharmaceutical, Inc. | $2,106 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $3,850 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $554 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $208 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $112 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $55 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $35 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $29 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-07 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $18 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-03 | Otsuka America Pharmaceutical, Inc. | $3,078 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-03 | Otsuka America Pharmaceutical, Inc. | $2,592 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $3,850 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $3,575 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $2,106 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $1,070 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $814 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $595 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $468 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $116 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $98 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $98 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $61 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $50 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | Axsome Therapeutics, Inc. | $41 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-30 | Otsuka America Pharmaceutical, Inc. | $225 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-30 | Otsuka America Pharmaceutical, Inc. | $225 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-30 | Otsuka America Pharmaceutical, Inc. | $85 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-30 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-26 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-24 | Otsuka America Pharmaceutical, Inc. | $110 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-24 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-23 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-22 | Collegium Pharmaceutical, Inc. | $9 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,400 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $61 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-16 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $142 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | Takeda Pharmaceuticals U.S.A., Inc. | $31 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-09-10 | Collegium Pharmaceutical, Inc. | $99 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-09 | E.R. Squibb & Sons, L.L.C. | $1,290 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-09 | E.R. Squibb & Sons, L.L.C. | $113 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-02 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-02 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-02 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-02 | Lundbeck LLC | $27 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-02 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $1,567 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $119 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $57 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $55 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $38 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $18 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $16 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-27 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-27 | Axsome Therapeutics, Inc. | $120 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-27 | Axsome Therapeutics, Inc. | $31 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-27 | Axsome Therapeutics, Inc. | $29 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-27 | Axsome Therapeutics, Inc. | $24 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $3,850 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $576 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $54 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $52 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $43 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $36 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-24 | Collegium Pharmaceutical, Inc. | $7 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-22 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-22 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-21 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-20 | ABBVIE INC. | $1,100 | Consulting Fee | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $3,850 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $1,759 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $806 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $306 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $65 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $53 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $48 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $26 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-19 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-19 | Axsome Therapeutics, Inc. | $19 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-15 | ABBVIE INC. | $550 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $1,380 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-14 | ABBVIE INC. | $89 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-14 | ABBVIE INC. | $45 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $3,289 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | Alkermes, Inc. | $800 | Consulting Fee | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-13 | ABBVIE INC. | $596 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $517 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $56 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-11 | Collegium Pharmaceutical, Inc. | $7 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-08 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ABBVIE INC. | $118 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-05 | Lundbeck LLC | $131 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-05 | Collegium Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-05 | Vanda Pharmaceuticals Inc. | $5 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-08-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5,720 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $454 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $297 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $99 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $27 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $1,137 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $10 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-28 | Axsome Therapeutics, Inc. | $2,750 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 |
The latest 200 records of 3,556.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In McLean, VA, county Fairfax County, VA, state Virginia; placed by its city name.
| Measure | Place (city or town) McLean, VA | County Fairfax County, VA | State Virginia |
|---|---|---|---|
| Population B01003 | 49,627 | 1,147,837 | 8,705,170 |
| Population, 2020 census P1 | 50,773 | 1,150,309 | 8,631,393 |
| Median age B01002 | 46.6 | 39.1 | 39.0 |
| Under 18 B01001 | 25.4% | 22.9% | 21.7% |
| 65 and over B01001 | 20.2% | 15.0% | 16.7% |
| Households B11001 | 17,147 | 414,101 | 3,365,732 |
| Foreign born B05002 | 25.0% | 30.8% | 13.1% |
| Median household income B19013 | $250,001 | $153,637 | $93,170 |
| Median family income B19113 | $250,001 | $183,217 | $115,213 |
| Per capita income B19301 | $131,068 | $71,828 | $50,666 |
| Poverty rate B17001 | 2.9% | 5.9% | 9.9% |
| Unemployment rate B23025 | 2.3% | 4.2% | 4.3% |
| Civilian labor force B23025 | 23,849 | 637,207 | 4,468,236 |
| Mean commute (minutes) B08013 | 28.1 | 28.9 | 27.3 |
| Bachelor's degree or higher B15003 | 84.3% | 65.0% | 42.2% |
| Housing units B25001 | 17,833 | 430,047 | 3,684,756 |
| Owner-occupied B25003 | 86.1% | 68.6% | 67.3% |
| Renters B25003 | 13.9% | 31.4% | 32.7% |
| Median home value B25077 | $1,412,700 | $732,800 | $383,700 |
| Median gross rent B25064 | $3,422 | $2,276 | $1,579 |
| White, not Hispanic B03002 | 65.2% | 46.8% | 58.4% |
| Black B03002 | 1.7% | 9.4% | 18.3% |
| Hispanic or Latino B03002 | 6.3% | 17.6% | 11.0% |
| Asian B03002 | 20.8% | 19.9% | 6.9% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in McLean, VA.
Comments